Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isoflurane-remifentanil versus propofol-remifentanil for bleeding control during microscopic ear surgery
IRCT20090415001815N2Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Nov 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of isoflurane, remifentanil and propofol in Ear Disorder (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Bleeding during surgery. Started Nov 2024; status: completed.
02
Drugs
isofluraneremifentanilpropofol
03
Conditions
Ear Disorder
Beyond the preview
Go deeper on IRCT20090415001815N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090415001815N2.